Gavin Macbeath

Gavin Macbeath

Company: TScan Therapeutics

Job title: CSO

Seminars:

Panel Discussion: Optimizing Development of Combination Approaches to Overcome the Solid Tumor Microenvironment 10:30 am

Exploring how to train T cells to overcome immune defence and survive in the low-nutrient, acidic and hypoxic tumour microenvironment Utilizing anti-PD1 antibody fragments secreted from T-cells after tumor interaction to overcome the local suppressive environment Profiling metabolic TME immuno-suppressive mechanisms through use of novel technology platformsRead more

day: Day Two

“Unbiased Discovery of Novel Targets for TCR-T using TargetScan” 11:00 am

T-cell targets of recovering COVID-19 patients were first discovered using a high-throughput, whole-genome reporter system Discovery of epitope targets in solid tumors is a major limitation for immunotherapy TScan’s system has discovered over 40 novel, shared cancer targets to date in solid tumorsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.